We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+5.2%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$32.7B
AUM Growth
+$8.12B
Cap. Flow
+$6.76B
Cap. Flow %
20.69%
Top 10 Hldgs %
11.63%
Holding
4,209
New
1,042
Increased
1,324
Reduced
1,059
Closed
704

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$271M
2
AAPL icon
Apple
AAPL
+$181M
3
MSFT icon
Microsoft
MSFT
+$171M
4
SBUX icon
Starbucks
SBUX
+$128M
5
AZO icon
AutoZone
AZO
+$113M

Sector Composition

Rank Sector Weight
1 Technology 11.74%
2 Consumer Discretionary 9.65%
3 Healthcare 6.66%
4 Financials 5.78%
5 Industrials 4.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PMVP icon
3326
PMV Pharmaceuticals
PMVP
$66.1M
$119K ﹤0.01%
19,041
-237,522
-93% -$1.24M
GRPN icon
3327
Groupon
GRPN
$980M
$119K ﹤0.01%
20,087
-35,392
-64% -$157K
WGS icon
3328
GeneDx Holdings
WGS
$1.75B
$118K ﹤0.01%
+19,737
New +$156K
TWIN icon
3329
Twin Disc
TWIN
$335M
$117K ﹤0.01%
+10,393
New +$114K
ATRA icon
3330
Atara Biotherapeutics
ATRA
$71.2M
$117K ﹤0.01%
2,903
-1,368
-32% -$77.4K
OXLC
3331
Oxford Lane Capital
OXLC
$830M
$117K ﹤0.01%
4,816
-848
-15% -$21.7K
BGC icon
3332
BGC Group
BGC
$5.58B
$117K ﹤0.01%
+26,308
New +$117K
OMIC
3333
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$116K ﹤0.01%
4,674
+3,702
+381% +$108K
GECC icon
3334
Great Elm Capital Corp
GECC
$72.5M
$116K ﹤0.01%
+14,965
New +$120K
XRN
3335
Chiron Real Estate Inc
XRN
$544M
$115K ﹤0.01%
2,528
+169
+7% +$7.63K
NG icon
3336
NovaGold Resources
NG
$2.6B
$115K ﹤0.01%
28,907
-2,906
-9% -$15.6K
FGBI icon
3337
First Guaranty Bancshares
FGBI
$153M
$115K ﹤0.01%
+10,240
New +$135K
ACHV icon
3338
Achieve Life Sciences
ACHV
$626M
$114K ﹤0.01%
+21,972
New +$154K
CNDT icon
3339
Conduent
CNDT
$230M
$114K ﹤0.01%
+33,531
New +$110K
VSTM icon
3340
Verastem
VSTM
$532M
$114K ﹤0.01%
+15,293
New +$106K
SPRO icon
3341
Spero Therapeutics
SPRO
$68.9M
$113K ﹤0.01%
+78,063
New +$134K
URGN icon
3342
UroGen Pharma
URGN
$2B
$113K ﹤0.01%
+10,920
New +$120K
FSR
3343
DELISTED
Fisker Inc.
FSR
$112K ﹤0.01%
+19,944
New +$115K
RLX icon
3344
RLX Technology
RLX
$2.48B
$112K ﹤0.01%
63,137
-140,960
-69% -$315K
CRGE
3345
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
$110K ﹤0.01%
+112,132
New +$114K
KVHI icon
3346
KVH Industries
KVHI
$177M
$108K ﹤0.01%
11,847
-10,061
-46% -$101K
ZVIA icon
3347
Zevia
ZVIA
$108M
$108K ﹤0.01%
25,106
-27,830
-53% -$107K
SUP
3348
DELISTED
Superior Industries International
SUP
$108K ﹤0.01%
+29,946
New +$122K
ORC
3349
Orchid Island Capital
ORC
$1.31B
$105K ﹤0.01%
+10,157
New +$105K
JBLU icon
3350
PUT
JetBlue
JBLU
$1.96B
$104K ﹤0.01%
11,700

Similar funds

Squarepoint's Q2 2023 Portfolio in Review

As of Q2 2023, Squarepoint held 4,209 positions worth $32.7B, up 33% from $24.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Squarepoint deployed $6.76B of net new capital in Q2 2023, opening 1,042 new positions and adding to 1,324 existing holdings. Its largest new stake was Home Depot: 275,512 shares worth $85.6M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Walmart Inc, an estimated $116M trimmed.

  • Squarepoint's largest Q2 2023 buy was Home Depot: 275,512 shares worth $85.6M.
  • Squarepoint added most to State Street SPDR S&P 500 ETF Trust in Q2 2023, an estimated $271M increase.
  • Squarepoint's biggest Q2 2023 reduction was Walmart Inc, cutting an estimated $116M.
  • Squarepoint fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2023, selling an estimated $208M.
  • Squarepoint's ten largest holdings make up 12% of its $32.7B portfolio in Q2 2023.
  • Squarepoint opened 1,042 new positions and closed 704 in Q2 2023.
  • Squarepoint's portfolio value rose 33% quarter-over-quarter to $32.7B.

Based on Squarepoint's 13F filing for Q2 2023, filed 14 Aug 2023.